2019 SUO Annual Meeting
SUO 2019 Prostate Cancer
- SUO 2019: Bipolar Androgen Therapy for Men with Castration Resistant Prostate Cancer
- SUO 2019: Optimal Management of Metastatic Castration Sensitive Prostate Cancer
- SUO 2019: PARP Inhibitors for Prostate Cancer
- SUO 2019: Implementation of Standard Opioid Prescribing Schedules Following Urologic Surgeries Reduces Opioid Prescriptions Without Change in Patient Reported Outcomes
- SUO 2019: Bipolar AR Therapy
SUO 2019 Kidney Cancer
- SUO 2019: Comparing Outcomes for mRCC Patients Treated in Clinical Trials Versus Population Based Studies
- SUO 2019: Employing Multiparametric Profiling to Characterize Immunotherapy Responders in Clear Cell Renal Cell Carcinoma
- SUO 2019: Better Outcomes at Higher Volume Centers: Evaluating Your Institution’s Data
- SUO 2019: The Role of Radiation in the Management of Renal Cell Carcinoma
- SUO 2019: The Therapeutic Landscape for Predictive Biomarkers in Renal Cell Carcinoma
SUO 2019 Bladder Cancer
- SUO 2019: MRI for Staging for Bladder Cancer & ViRads System
- SUO 2019: Active Surveillance versus Office Fulguration or Laser Treatment
- SUO 2019: En Bloc Resection
- SUO 2019: Response of FGFR3 Alterations In High-Grade Non-Muscle Invasive Bladder Cancer Treated with Intravesical BCG Therapy
- SUO 2019: Liquid Biopsy Analysis of TERT Promoter and FGFR3 Mutations in Urinary Cell-Free DNA in Upper Tract Urothelial Carcinoma